A webinar focusing on the triple helix model, the Swedish Teachers’ Exemption, and how these frameworks spur academic innovation from the lab to bedside care. The event was co-hosted by the Embassy of Sweden in Washington, DC, Dana-Farber Cancer Institute, Harvard Medical School,Uppsala University, and Oncopeptides AB. Photo Credits: Melker Dahlstrand/imagebank.sweden.se
A webinar focusing on the triple helix model, the Swedish Teachers’ Exemption, and how these frameworks spur academic innovation from the lab to bedside care. The event was co-hosted by the Embassy of Sweden in Washington, DC, Dana-Farber Cancer Institute, Harvard Medical School,Uppsala University, and Oncopeptides AB.
